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Summary 
Human natural killer (NK) cell differentiation from immature lineage negative (Lin-) umbilical 
cord blood cells was examined in vitro.  Cells expressing differentiation antigens of mature NK 
cells (CD56,  CD16,  CD2, CD8, NKR-P1A) were generated from Lin- cells cultured with m- 
terleukin  (IL)-2 and a murine bone marrow stromal cell line expressing the human membrane- 
bound form of stem cell factor. Two subsets of NK cells were identified in these cultures:  one 
expressed both NKtL-P1A and CD56 and, in variable proportions, all other NK cell differenti- 
ation  antigens;  the  second  subset  expressed only NKR-P1A  and,  unlike  the  former, was not 
cytotoxic.  Neither  subset  expressed  interferon  (IFN)-y  mtLNA  even  after  stimulation  with 
phorbol di-ester and Ca  2+ ionophore, but both expressed tumor necrosis factor ot mRNA  and 
the  cytotoxic  granule-associated  proteins  TIA-1,  perforin,  and  serine  esterase-1.  After  10-d 
culture  with  IL-2,  IL-12,  and  irradiated  B  lymphoblastoid  cells,  ~45%  of the  NKR.-PIA+/ 
CD56-  cells became CD56 +, and the same cultures contained cells capable ofcytotoxicity and 
of IFN-y production.  These results indicate that NKR.-P1A expression in the absence of other 
NK cell  markers defines  an intermediate,  functionally  immature  stage of NK cell differentia- 
tion,  and that effector functions  develop in these cells,  concomitantly  with CD56  expression, 
in the presence of IL-12. These cells likely represent the counterpart of a CD3-/NKR-P1A+/ 
CD56  /CD16-  cell subset that,  as shown here, is present both in adult and neonatal circulat- 
ing lymphocytes. 
N 
K  cells are a lymphocyte subset distinct from B  and T 
cells, lacking expression of the antigen-specific recep- 
tors present on these cell types (T and B  cell receptors, i.e., 
TCP,. and slg/BCl<)  (reviewed in reference  1). They rep- 
resent  -~15%  of the  circulating  lymphocytes  in  adult  and 
neonatal  peripheral blood  (2),  are effectors of nonadaptive 
immunity, are cytotoxic, in the absence of known presensi- 
tization,  to a variety of target cells, and, via IFN-y produc- 
tion,  they  facilitate  the  development  of Th0  to  Thl  cells 
(3),  thus  promoting  cell-mediated  immune  responses  (4). 
No unique NK cell marker has been identified yet, but ex- 
pression of a set of differentiation antigens in the absence of 
antigen-specific receptors ofT and B lymphocytes serves to 
identify these  cells.  CD16  and  CD56  are expressed,  either 
alone  or  in  combination,  on  the  majority  of mature  NK 
cells  (2).  Other  antigens  expressed  on  subsets  of NK  cells 
include  CD8  (30-50%)  (5), and CD2  (50-70% of NK cells 
from  umbilical  cord  blood  and  >90%  of NK  cells  from 
adult blood)  (2). 
Human NK cell progenitors exist in the lineage negative 
(Lin-)l/CD34 +  subset of hematopoietic  cells that includes 
mulfilineage progenitors and hematopoietic stem cells  (6-10). 
A  variety  of in  vitro  culture  conditions,  requiring  IL-2, 
IL-15, and/or bone marrow stromal cells (7, 8) or stem cell 
factor  (SCF)  (9,  10),  or  IL-15  (11)  support  differentiation 
of these cells to mature CD56 + cytotoxic NK cells. CD7 is 
expressed on early NK cell progenitors;  these have growth 
factor requirements  distinct  from those  of more differenti- 
ated cells: CD7+/CD34 + NK cell progenitors require bone 
marrow stromal cells and IL-2 to differentiate into  CD56 + 
cytotoxic cells (7), while CD7+/CD34-/CD56  -  cells, rep- 
resenting  more  mature  progenitor  cells  in  umbilical  cord 
blood,  require  only IL-2  (12).  In the  murine  system,  NK 
cells at distinct stages of differentiation have been identified 
based  on  surface phenotype;  non-stem  cell hematopoietic 
1Abbrewations used in this paper" ADCC, antibody-dependent cell-me&ated 
cell to:rdclty; GaMIg, goat anti-mouse  Ig; Lm-, hneage negative; MSE, 
monocyte-specific esterase; tLT, reverse transcripnon, SCF, stem cell fac- 
tor; SE, senne esterase 
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antigens develop into mature cytotoxic NK cells in adoptive 
transfer experiments (13,  14).  Conjugate-forming, noncy- 
totoxic,  putative  pre-NK  cells  that  express  NKR-P1C 
(NKI.1) in the  absence of other mature NK cell markers 
have been identified in mice in which, after bone marrow 
ablation, NK cell differentiation is incomplete (15). 
Differentiation antigens that identify human NK cells at 
intermediate  stages  of differentiation at  which  they  have 
unequivocal, although possibly incomplete, NK cell phe- 
notype, and at which they are functionally immature have 
not been described. In addition, the specific sequence with 
whxch  human  NK  cells  acquire  differentiation  antigens 
and/or functions, and the  growth  factors  supporting NK 
cell  development/differentiataon  have  been  determined 
only in part.  Here we  report the identification of a func- 
tionally immature, noncytotoxic NK cell subset, character- 
ized by the expression of NKR-P1A and lack of other NK 
cell differentiation antigens, that can be induced to  differ- 
entiate to functionally and phenotypically mature NK cells 
in the presence oflL-12. A subset of adult and neonatal cir- 
culating NK cells was also identified, that has a surface phe- 
notype similar, if not identical, to that of the immature NK 
cells generated in vitro. 
Materials and Methods 
Monodonal and Polydonal  Antibodies.  Most mAbs used have been 
characterized  previously in our laboratory.  They include: CD2 
(B67.1, and B67.6),  CD4 (B66.6), CD5 (B36.1), CD8 (Bl16.1), 
CDllb ~B43.4), CD14 CB52.1), CD15 (B40.9), and CD56 (13159.5) 
(2,  16). mAbs to  CD3  (OKT3)  (17), CD21  (THB5)  (18), and 
CD34  (MY10)  (19) were  produced  from  cells obtained from 
American Type Culture Collection (Rockville, MD).  mAb to 
CD94 (HP3B1)  (20) was kindly provided by Dr. M. Lopez-Botet 
(Hospital  de  la  Princesa,  Madnd,  Spain).  PE-anti-CD16 mAb 
(B73.1-PE)  (2)  was from Becton Dickinson and Co.  (San Jose, 
CA). PE-anti-CD56 (N901)  and the FITC-labeled mAb to CD7 
(3A1), CD8 (T8),  CD25  (1HT44H3), and CD122  (2RB)  were 
from Coulter Corp. (Hialeah, FL). 
mAb B199.2  was produced from a fusion, performed as prew- 
ously reported (2), of the P3x63-Ag8.653 nonsecretor myeloma 
cells with splenocytes  from a BALB/c mouse immunized (three 
times  lntraperitoneally at  weekly  intervals,  and  once  intrave- 
nously 3 d before fusion) with purified human NK cells, prepared 
as described previously (16) and cultured for 3 d with IL-2. This 
mAb (IgG2b,  as determined by xmmunodiffuslon with lSOtype- 
specific antibodies) detects NKR-P1A on NK cells and subsets of 
CD4 + and CD8 + T cells (not shown), as indicated by the obser- 
vauons that:  (a) it immunoprecipitates from mature NK cells an 
80-kD  surface  molecule, a  disulfide-linked homodimer of two 
40-kD chains (Zatsepina,  O., and B. Perussxa, unpubhshed data); 
(b) it cross-competes  with the anti-NKR-PIA mAb DX-1  (21) 
for binding to NK cells; and (c) it reacts with NKR-PIA-trans- 
fected,  but not untransfected,  murme L  cells (assay kindly per- 
formed by Dr.  L.  Lanier,  DNAX, Palo Alto,  CA).  When indi- 
cated,  this  and other rnAbs were  labeled  with biotin or  FITC 
according to standard  procedures,  after purification from ascltes 
on protein  G-Sepharose  (Pharmacia  Fine Chemicals,  Uppsala, 
Sweden)  columns. 
The polyclonal goat anti-mouse Ig (GaMIg) used for panning 
was produced in our laboratory,  adsorbed on human Ig and affin- 
ity-purified on mouse tg-Sepharose  before use  (16). The rabbit 
IgG  anti-sheep  erythrocyte  used  to  prepare  immune complex 
monolayers was from Cappel (Durham, NC). 
Cell Isolation.  Umbilical cord blood, collected  at delivery and 
anticoagulated with  heparin,  was  kindly provided  by  Dr.  tL. 
Depp (Department of Obstetrics and Gynecology, Thomas Jeffer- 
son University Hospital,  Philadelphia,  PA). PBMC were isolated 
on  Facoll/Hypaque density gradient  (Histopaque-1077;  Sigma 
Chemical Co., St. Louis, MO) and contaminating  erythrocytes were 
lysed using NH4C1 buffer (0.15 M NH4C1, 0.01 M KHCO3, 0.1 
mM EDTA; 4°C, 10 min). PBL were isolated from PBMC after 
adherence to plastic (37°C, 20 mln). The majority of T and NK 
cells were depleted after rosettmg with 2-ammoethylisothlouro- 
mum  bromide  (hydrdorormde)  (Sigma  Chemical  Co.)-treated 
sheep E  (21). PBL not forming E-rosettes  were collected  at the 
interface  of Ficoll/Hypaque density gradients  and Fc~/R  + (NK, 
B, and myelo-monocytic) cells  were depleted after incubation on 
rabbit IgG immune complex monolayers as described  (22). Re- 
sidual mature hematopoietic cells were depleted from the Fc~/tL- 
cells by indirect anti-Ig panning (23) (30 min, 4°C)  on GaMIg- 
treated  polystyrene petri dishes after sensitization with a panel of 
mAbs to differentiauon antigens on mature hematopoietlc cells, 
including mAb (clones listed above)  to CD2, CD3, CD4, CD5, 
CD8, CD11b, CD14, CD15, CD21, CD56, CD94, and NKtL- 
PIA. The procedure was repeated  three times to maxan~ze deple- 
tion.  These  populations,  referred  to  as  Lin-  cells, were  >99% 
CD3-/CD56-/NKIL-P1A-/CD16 ; the malonty of them (81.2 + 
9.7%, n =  9) were HLA-DR  + and contained 57.6 +  19.7% (n =  7) 
CD34 + cells, as determined by indirect immunofluorescence. 
When indicated, resting NK cells were prepared from adult and 
umbilical cord blood PBL  after  sensitization  with a rmxture of 
mAb to CD3, CD4, CD5, CD14, CD15, CD21, and CD34 and 
panning. The resulting cell populations contained 81.1  +  5.8% 
NKR-P1A  + and 1.8 +  0.6% CD3 + cells (n =  7), as tested in in- 
direct lmmunofluorescence; CD3+/NKR-P1A  + cells were  un- 
detectable.  Homogeneous NK cell populations were also punfied 
from 10-d cultures of umbilical cord blood PBL with the B-lym- 
phoblastoid tLPMI 8866 cell line (16). 
NKR-P1A~/CD56  + and NKR-P1A+/CD56  -  cells were pu- 
rified from day-30 cultures of Lin- cells (see below) by indirect 
anti-Ig panning. For this, CD56 + cells were selected  (procedure 
repeated twice)  after sensitization with anti-CD56 mAb. Homo- 
geneous NKR-P1A+/CD56  -  populations were then prepared from 
the CD56  cells  after sensitization with B199.2.  The cell popula- 
uom obtained were >99% NKR-P1A+/CD56  -' and NKR-P1A+/ 
CD56 +,  respectively, as  determined by indirect lmmunofluo- 
rescence. 
Hematopoietic Progenitor Cell Cultures.  Lin- cells were cultured 
(37°C, 8% CO  2 atmosphere)  in 24-well ussue culture plates (2 X 
105 cells/well)  m 2 ml RPMI 1640 medium (BioWhittaker Inc., 
Walkerswlle,  MD) supplemented with 10% heat-inactivated fetal 
bovine serum (FBS; Sigma Chemical Co.) on a confluent mono- 
layer of 30-Gy irradiated murine S1/S14 bone marrow stromal cell 
hne or its denvative S1/SPhSCF 22°, expressing membrane-bound 
SCF  (24) (provided by Dr.  D.  Williams, University of Indiana 
School of Medicine, Indianapolis,  IN). Recombinant (r) IL-2 (50 
U/ml, sp act 1.1  ×  106 U/rag protein, obtained from the Biolog- 
ical Response Modifiers Program,  National Cancer Institute, Be- 
thesda, MD) was added at the beginning  of the cultures and every 
4 d during a 30-d culture penod. The culture medium was par- 
tially replaced  every 7 d,  and nonadherent cells from mdiwdual 
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age).  These  culture  conditions  are  referred  to  as  "primary  cul- 
tures." 
For secondary cultures,  106 NKR-PIA+/CD56 + and CD56 
cells, separated as described above from day-30 primary cultures, 
were cultured for 10 d  in 2  ml medmm/well of 24-well culture 
plates,  rlL-2  (50 U/ml) and  rlL-12  (1  ng/ml,  sp  act 4.5  ×  106 
U/mg protein  in an  IFN-'y induction assay;  kindly provided by 
Dr. S. Wolf, Genetics Institute, Andover, MA) were added at the 
beginning of the culture and every 4 d afterward. Daudi cells (30-Gy 
irradiated) were added (2 ×  105 cells/well). 
Immunofluorescence  (Flow Cytometry).  One-,  two-,  and  three- 
color lmmunofluorescence analysis  was performed with the indi- 
cated FITC-, PE-, or biotin-labeled mAb as previously described 
(2,  16).  FITC- (Vector Laboratories, Burhngame,  CA), PE- (Bec- 
ton Dickinson and  Co.),  or P,.670-  (Gibco  BR.L,  Gaithersburg, 
MD) labeled streptavidin were used to detect biotin-labeled mAb. 
Samples were  analyzed  on an EPICS  Elite,  or a  Profile-II flow 
cytometer (Coulter Corp.). 
Cell-mediated  Cytotoxicity.  This was tested in 4-h 51Cr release 
assays using K562  or P815  cells sensitized with anti-P815  rabbit 
serum  as  targets  for  spontaneous  and  antibody-dependent  cell- 
mediated cytotoxicity (ADCC), respecnvely (2). Target cells were 
104/well. When indicated,  effector cells were incubated  (5  ×  106 
cells/ml  18 h, 37°C) with rlL-2 (50 U/ml) and rlL-12 (4 ng/ml) 
before testing. 
Reverse  Transcription  (RT)  PCR.  Cells  were  incubated  (5  × 
106 cells/ml, 2 h, 37°C)  or not, as indicated, in medium without 
or with  PMA  (10 -9  M;  Sigma  Chemical  Co.)  and  Ca  2+  iono- 
phore  (A23187,  0.1  I~g/ml; Sigma Chemical Co.).  Total R.NA 
was extracted from 2.5  ×  105 cells using RNAzol (Biotecx Labo- 
ratories, Houston, TX) after the manufacturer's protocol, mRNA 
was reverse-transcribed using Moloney murine leukemia virus re- 
verse  transcnptase  and  ohgo-dT  3'  primer  (37°C,  1  h).  The 
primer pairs  were  designed to span  lntronic  regions,  to prevent 
genomxc DNA amplification. CD16 cDNA was amphfied (30 cy- 
cles)  using previously described oligonucleotide primers and con- 
ditlons  (25).  Primers  (synthesized at the Kimmel Cancer Center 
Nucleic Acid Facility) were:  No.  616:  sense  GGG  GGC  TTG 
TTG GGA GTA AA; No. 485: antlsense GAG AGG CCT GAG 
GAT GAT. The 13 actin primers were derived from the murine 
sequence  (sense TGG GAA TGG GTC AGA AGG ACT; anti- 
sense TTT CAC GGT TGG CCT TAG GGT T) (30 amphfica- 
tlon cycles: melting, 94°C; annealing, 55°C; extension, 72°C; 1 rain 
each).  IFN-~/  (sense  GCA TCG  TTT  TGG  GTT  CTC  TTG 
GCT  GTT  ACT  GC;  antisense  CTC  CTT  TTT  CGC  TTC 
CCT  GTT  TTA  GCT  GCT  GG),  and  TNF-oL  (sense  GAG 
TGA CAA  GCC  TGT  AGC CCA TGT TGT AGC A; antx- 
sense  GCA  ATG  ATC  CCA  AAG  TAG  ACC  TGC  CCA 
GAC) primers were purchased from Clontech Laboratories,  Inc. 
(Palo Alto, CA) (30 cycles: melting, 1 nun, 94aC; annealing, 1 rain, 
60°C; extension, 2 min, 72°C). Monocyte-specific esterase  (MSE) 
cDNA was  amplified using previously described oligonucleotide 
primers  (sense  GGC  AGT  TAC TCT  CAG AGG  CTA;  anti- 
senseq2TT  CCA CAG GAG TGA CAT GGC)  and  conditions 
(26).  PCR products were electrophorese~! in 2% agarose gels and, 
when  indicated,  transferred  to  nylon  membrane  (Hybond-N; 
Amersham Corp., Arlington Heights, IL) and hybridized to specific 
oligonucleotlde probes  (CD16,  No. 465: TCA TTT GTC TTG 
AGG  GTC  [25];  13  actin,  AGC  AAG AGA GGT  ATC  CTG 
ACC  CTG  AAG  TAC  CCC  ATT  GAA;  MSE,  GGT  TCT 
TGG CCA ATG GAG ACA). These were labeled with ~/-[3/p]ATP 
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Figure 1.  Surface phenotype of umblhcal  cord blood lymphocytes.  Two-color lmmunofluorescence  (flow cytometry)  was performed with the indi- 
cated mAb on umblhcal cord blood PBL. The mAb were labeled with FITC (green fluorescence), PE (red fluorescence), or bxonn (detected with strepta- 
vldln-PE).  Correlate measurements  of red (x axis, log scale), and green  (y axis, log scale) fluorescence are &splayed as two-dimensional  contour plots. 
Based on the negative control samples in the presence of FITC- and PE-streptavldin  only (not shown), the contours were divided into quadrants: (top left) 
cells with green fluorescence (binding FITC-labe]ed antibody only); (top right) double-posmve cells; (bottom right) cells with red fluorescence (binding PE- 
labeled antibodies only), (bottom left) double negative cells. Percent positive cells (background subtracted) m each quadrant are indicated. The numbers on 
the x and y axes are arbitrary units  of fluorescence intensity (log scale). 
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Figure 2.  Identification  of CD3  /NKR-P1A+/CD56-/CD16  lymphocytes  m adult and umbdical  cord blood.  Three-color lmmunofluorescence 
was performed on CD3- PBL. Antigen expression was analyzed on adult (/t) and umbilical cord blood (A and B) PBL, electronically gated on NKtL- 
PIA  + cells identified with biotin-labeled  B199.2 and R670-streptavldm.  The indicated surface antigens were detected with FITC- or PE-labeled Ab, as 
descnbed m Fig. 1. x axis, red, y axis, green fluorescence. 
(sp  act>3,000  C1/mmol;  NEN  DuPont,  Boston,  MA)  and  T4 
polynucleotide kinase  (27).  All enzymes and  the ~bX174  DNA/ 
HaelII  molecular  weight  markers  were  from  Promega  Corp. 
(Madison, WI). 
IFN-  T and TNF-a RIA.  These were performed as previously 
described  (28,  29)  on  the  cell-free supernatants  from  cells cul- 
tured for the times specified in the indicated conditions, using the 
mAb  pairs  B133.1,  B133.5  (anti-IFN-',/)  and  B154.2,  B154.7 
(anti-TNF-e  0. Purified natural  IFN-y (Interferon Sciences, New 
Brunswick,  NJ),  and  rTNF-oL  (provided by Dr.  H.M.  Shepard, 
Genentech  Inc.,  South  San  Francisco,  CA)  were  used  as  stan- 
dards. 
Immunocytochemistry.  Cells (3  X  104) were cytocentrifuged on 
poly-L-lysine-treated slides,  fixed in  acetone  (-20°C,  10  rmn), 
and stored at -80°C until use.  mAb to TIA-1 (30)  (IgG, 5 Ixg/ml; 
Coulter Corp.)  and  to tL-12 p40  (31)  (C8.1,  ascites,  10 -3 dilu- 
tion;  provided by Dr.  G.  Tnnchien,  Wistar  Institute,  Philadel- 
phia, PA), rabbit anti-mouse perforin antiserum cross-reacting with 
human  perforin  (32)  (provided  by  Dr.  C.-C.  Era,  The  Rock- 
efeller University, New York)  or control nonimmune rabbit se- 
rum (both  10 -2 dilution) were added to the rehydrated cells.  Af- 
ter  incubation  and  washings,  positive  cells  were  detected  with 
biotin-labeled  GaMIg  or  goat  anti-rabbit  Ig and  biotm-labeled 
horseradish peroxidase-avidm complex (ABC kit; Vector Labora- 
tories, Burhngame,  CA) and diaminobenzidine (Sigma Chemical 
Co.) substrate, following the manufacturer's instructions. Staimng 
was intensified using the diaminobenztdme intens~ficatlon reagent 
(Vector Laboratories),  and hematoxylin was used to counterstain 
the nuclei. 
Single-cell NoL-benzyloxycarbonyl-L-lysine-thiobenzyl ester,  hy- 
drochloride  esterase  assays to  detect  senne  esterase  (SE)-I  were 
performed,  according to pubhshed  procedures  (33),  on cytocen- 
trifuge preparations  of NKR-P1A+/CD56 + or CD56- cells pre- 
pared as described above from 30-d cultures. 
Statistical Analysis.  Data  were  analyzed  using the two-tailed, 
two-sample t test (Minitab statistical analysis  software; State Col- 
lege, PA). P <0.05 were considered significant. 
Results 
Identification of a CD3  /NKR-PIA +/CD56-/CD16-  Lym- 
phocyte Population within Adult and Umbilical Cord Blood.  As  in 
PBL from adults  (34,  and data not shown),  CD3-/CD56  + 
and  CD3-/CD16  ÷  NK  cell subsets  were  detected in  um- 
bilical  cord  blood  PBL.  The  majority  (>70%)  of  the 
CD16 +  cells  expressed  CD56,  and  >90%  of the  CD56 + 
cells expressed  CD16,  as determined  by two-color immu- 
nofluorescence  (flow  cytometry)  (Fig.  1,  top).  NKR-P1A 
was  expressed  on  all CD16 +  and  CD56 +  NK  cells,  there- 
fore identifying most,  if not all, neonatal  NK  cells, and  on 
25%  of the  CD3 +  T  lymphocytes  (Fig.  1,  bottom).  As  in 
adult  PBL  (not shown)  NKR-P1A  was  expressed  on most 
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Figure  3.  Phenotype of Lin  cells (A)  Two-color immunofluores- 
cence analysis  was performed on Lm- umbihcal cord blood cells  as m Fig. 1; 
x axis, PE-labeled Ab; y axis FITC-labeled Ab. Percent positive cells per 
quadrant are indicated. (B) Spontaneous cytotoxacaty (F~, .)  and ADCC 
(A,  &)  were  measured an a 4-h 51Cr release assay using the ]ndicated 
number of effector cells and 104 K562 or Ab-coated P815 target cells, re- 
spectwely  Effectors were total (B, &) and Lin- cells ([], A) premcubated 
(18 h, 37°C) with rlL-2 (50 U/ml) and rIL-12 (4 ng/ml), as descnbed an 
Materials and Methods.  (C) Expressmn of CD 16 and [3 actm mP,  NA was 
analyzed by RT-PCR. Total mP,  NA was extracted from the re&cared 
cell types  and RT-PCR  was  performed  as described in Matenals  and 
Methods. PCI< products were electrophoresed on 2% agarose gels, trans- 
ferred to nylon membranes, and hybndlzed to 32p-labeled gene-specific 
internal ohgonucleotlde probes. 
CD8 +&m NK cells but only on a proportion ofCD8 +h'gh T 
cells and CD2 +  cells. 
Three-color immunofluorescence was performed to ana- 
lyze directly the phenotype of the CD3-/NKR-P1A  + NK 
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cells. Fig. 2  shows two-color histograms of CD3-  lympho- 
cytes purified from umbilical cord blood and electronically 
gated on the NKP,-P1A +  cells.  These  contained CD16+/ 
CD56 +  (68.0  ---  4.7%),  CD16+/CD56 -  (18.2  +  4.3%), 
and CD16-/CD56  +  (12.4  -+  5.9%)  subsets (mean  +  SD, 
n  =  4). An additional NKl~-PIA+/CD16-/CD56  -  subset 
was also detected in PBL from both neonates (4.2  _+  1.7%, 
n  =  4)  and  an  adult  donor  (Fig.  2  A).  CD7  and CD11b 
were  expressed  on  most  umbilical  cord  blood  NKR- 
P1A+/CD16-/CD56  -  NK cells while CD2 was expressed 
on ~50%  of the cells (4.8 vs 4.4%), similar to their expres- 
sion  in  the  total  NK  cell  population  (Fig.  2  B).  CD122 
(IL-2R.[~/)  and CD25  (IL-2R.~x)  were  detected  on ,'-'50% 
(3.1% vs 3.7%)  and 35%  (2.6% vs 4.5%)  of the cells in the 
same subset, respectively. 
Generation of Noncytotoxic NKR-PIA +/CD56-/CD 16- 
NK Cells  from Lin  Mononuclear Cells.  The Lin- cell pop- 
ulations, mosdy HLA-DP, +,  included ~80%  CD34 +  cells 
and did not contain detectable CD56 +  (Fig. 3  A), CD16 +, 
or NKR-P1A +  cells (not shown), as tested by indirect im- 
munofluorescence. They did not mediate spontaneous cy- 
totoxicity or ADCC  even after  18-h incubation with IL-2 
and IL-12  (Fig.  3  B)  and did  not  contain cells expressing 
CD16 mR.NA, as detected using RT-PCP,  (Fig. 3  C) with 
sensitivity to detect 1 in 5  ×  105 CD16 + cells (not shown). 
Several  culture  conditions  (Table  1)  were  analyzed  for 
their ability to support NK  cells' generation from the Lin- 
populations and/or mature NK  cells survival/proliferation. 
PBL from umbilical cord blood, and CD3-/NKI<-P1A + NK 
cells purified from them,  did not proliferate when cultured 
with S1/S14hSCF  22° and IL-2, and the latter died within 14 d. 
Instead, significant proliferation of Lin- cells occurred dur- 
ing the  first  15  d  of culture  in the  same  conditions  (total 
number of cells per well was  1.2  +  0.8  ×  106, mean -+ SD 
of 5-15-d cultures, n  =  7). At this time, myelo-monocytic 
CD64 +  cells constituted the majority of the cells and a sig- 
nificant number of CD34 +  cells was present only until this 
time  (data  not  shown).  After  a  decrease  at  intermediate 
times (Fig. 4), the total cell numbers by day 30 were similar 
to those in the initial 2  wk (3.3  -+ 2.1  ×  106 cells per well, 
mean +  SD of 26-39-d cultures, n  =  4). NKR-P1A+/CD3 - 
cells, expressing or not CD56 and cytotox]c to K562 target 
cells  (not  shown)  were  present  in the  cultures by  day  11 
(2.3  +  2.9  ×  105 cells per well, mean +  SD of 5-15-d cul- 
tures,  n  =  7,  and  representative  experiment  in  Fig.  4). 
Starting at nearly day 20, their numbers increased until day 
39, the last time point examined, as shown in the same fig- 
ure  (the  total  numbers  of CD3-/NKR-P1A  +  cells/well 
were 2.7  +  0.9  X  10  s,n=  5, and 2.1  +  1.0  ×  106  ,n=4, 
in 16-25- and 26-39-d cultures, mean +  SD). 
After 20 d, two CD3-/NKR-PIA  + NK cell populations 
were detected in the cultures: one (40.2  +  21.5%, mean + 
SD,  n  =  9)  was  CD56 +,  the  other  (57.9  -+-  23.2%)  was 
CD56-  (Fig. 5, top). Most, if not all, CD3  cells expressing 
CD16,  CD2,  or CD8  were  included in the CD56 +  subset 
(Fig. 5, bottom). CD7 and cytoplasmic CD3~ were detected 
in most cells in both subsets (data not shown). 
Cytotoxic Activity of NKR-PIA +/CD56- NK Cells.  The Table  1.  Generation  of CD3- /NKR-PIA + Cells from  Umbilical Cord Blood Lin  Cells 
Cell population*  Culture con&tions  IL-2:~  CD3-/NKIL-P1A +  cells/well,  X  1049 
PBL 
Purified NK cells 
Lin  cells 
S1/S14hSCF  22°  +  0.3, 0.3  (2) 
S1/S14hSCF  220  +  ndll  (2) 
S1/S14  -  nd  (2) 
S1/SI  4  +  nd  (2) 
S1/S14hSCF  22°  -  nd  (4) 
S1/S14hSCF  22°  +  22.6 +  15.0  (10) 
*The indicated cell types were cultured for 10-25 d (2  ×  10  s cells/well) in the condiuons listed 
:~rlL-2, 50 U/ml, was added every 4 d. 
~The number ofCD3-/NKK-P1A  + cells recovered at the end of the culture was calculated as the product of the percent positive cells (detected by 
lmmunofluorescence) by the number of total viable cells. The mean ±  SD is indicated, when appropriate, and the number of expenments performed 
in each condition IS indicated in parentheses. 
lind, not detectable 
NKR-P1A  +  cells  obtained  after  25-d  culture  were  cyto- 
toxic to the K562 target cells  (Fig. 6 A). The CD56 ÷, but 
not the  CD56-,  subset purified  from them was  cytotoxic 
against the same target cells (Fig. 6 A). The granule-associ- 
ated protein  TIA-1 was  expressed  in  90.0  +  3.0%  of the 
CD56 ÷ cells  (mean +  SD, n =  3), as tested by immunocy- 
tochemistry  (Fig.  6  B);  the  same  protein  was  detected  in 
64.0  +  15.0%  of the  CD56-  cells.  Cells  expressing  SE-1 
and  perforin  were  detected  in  each  subset  in proportions 
similar to those seen for TIA-1 (data not shown). 
Induction  of NKR-PIA+  /CD56 -  NK  Cells'  Differentia- 
tion.  To test the hypothesis that the NKR.-P1A+/CD56 
cells were immature NK cells with potential to differentiate 
further, homogeneous populations of these cells were puri- 
fied from day-30 cultures,  and were  cultured for 10 addi- 
tional days in the conditions listed in Table 2. Cell viability 
was maintained  in all  conditions,  but a significant propor- 
tion of CD56 +  cells  (43.2  +  25.9%,  mean  +  SD,  n  =  7) 
was  detected  only in  cultures  with  irradiated  Daudi  cells, 
IL-2,  and  IL-12  (P  <0.05)  and  the  cells  from these  cul- 
tures,  like  those  from cultures  of the  CD56  +  subset  (not 
shown) were cytotoxic to K562 target cells  (Fig. 7). NKK- 
P1A  expression  and  viability  of the  CD56 +  subset  were 
maintained  throughout  secondary  culture  in  each  of the 
culture conditions (data not shown). 
As shown in Fig. 8, NKR-P1A+/CD56 -  cells from 30-d 
cultures expressed no detectable  IFN-y mKNA  even after 
stimulation  with phorbol diester and  Ca  2+ ionophore.  In- 
stead, IFN-',/mR.NA was detected in the same populations 
after  10-d  secondary  culture.  Both  CD56 ÷  (not  shown) 
and  CD56-/NKR-P1A +  cells  (Fig.  8)  expressed  TNF-oL 
mRNA  constitutively both before and after secondary cul- 
ture. Minimal amounts of IFN-',/and TNF-ci were present 
in  the  supernatants  from primary cultures  (up  to  day 30); 
instead, both cytokines were detected at significant levels in 
cell-free  supernatants  collected  during  secondary  culture 
(Table 3). 
Discussion 
In this  study,  we identify a  discrete  subset  of immature 
NKK-P1A+/CD56  human NK cells and its requirements 
for  differentiation  to  phenotypically  mature  CD56 +  NK 
cells  capable ofcytotoxicity and IFN-~/production. 
NK cells were generated in cultures containing SCF and 
IL-2. Because mature  NK cells  could not be generated  in 
the  absence  of SCF,  both  cytokines  are  necessary for this 
process. Shibuya et al.  (9) proposed that, in the presence of 
SCF,  CD34 +  early NK cell progenitors in the bone mar- 
row  are  sequentially  sensitive  to  1L-3  and  IL-2,  and  be- 
come  sensitive  to  IL-2  and  SCF  independent  only  after 
they reach the stage of differentiation at which they express 
CD122  and  CD56.  Our  data  support  a  minimal  require- 
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Figure 4.  Kmencs of generation of NKR-P1A + cells. Lm- cells (2  X 
105/well) were cultured on SI/S14hSCF  22~ cells with IL-2  The percentage 
of CD3-/NKR-P 1A + cells was evaluated  by lmmunofluorescence on the 
indicated  days, and the number of viable  cells was counted. The absolute 
number of cells expressing NKtL-PIA was calculated  as the product of 
the percentage ofmAb  + cells by the number of viable  cells present at the 
indicated  time points. 0, total cells; [Z, NK1L-P1A  + cells (representanve 
experiment). 
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Figure  5.  Surface phenotype of day-28 primary culture cells  Lm- cells were cultured as in Fig. 4.  Two-color lmmunofluorescence analysis was per- 
formed,  as m  Fig.  1,  using the indicated FITC-  and PE-labeled antibodies, on  cells collected after 28-d cultures• x  axis, red fluorescence  (PE);  y axis, 
green fluorescence (FITC). 
ment for SCF and IL-2 in NK cell differentiation in vitro, 
but do not exclude a role for other cytokines including, but 
possibly not limited  to,  IL-3 and produced by cells  in the 
heterogeneous CD34 + or Lin- populations.  One such cy- 
tokine is likely represented by IL-15 (11). Cytokines possi- 
bly produced by the stromal cell line used as feeder are un- 
likely to be relevant  to this  process,  because  most murine 
cytokines  are  ineffective  on  human  cells.  These  findings 
contrast  with  reports  indicating  that  IL-2 is  sufficient  for 
NK  cell  maturation  (6).  However,  in  that  study  formal 
proof of the absence of contaminating mature NK cells was 
not presented•  Mature  NK cells  proliferate  in response  to 
IL-2 (35)  and SCF-induced proliferation of a minor subset 
of c-kit receptor + NK cells has been reported (36). We ex- 
clude that IL-2-dependent proliferation of residual mature 
NK cells m  the Lin-  cell populations accounts for the NK 
cells  generated  in our culture  conditions because:  (a)  IL-2 
alone  did  not support  NK  cell  generation  from the  Lin 
populations;  (b) Lin- cells do not mediate spontaneous cy- 
totoxicity or ADCC; (c) CD56 + and/or NKR-PIA + cells, 
or cells expressing CD16 mRNA  are not detectable in the 
Lin  cells  by  immunofluorescence  or  RT-PCR,  respec- 
tively; (at) mature NK cells  do not proliferate in conditions 
that support, instead, NK cell differentiation from the Lin- 
cells; and  (e)  the surface phenotype and functional proper- 
ties  of the  cells  generated  in  culture  differ from those  of 
most circulating NK cells,  including the  CD56+bnght/c-kit 
receptor +  NK  cell  subset  reported  by  Matos  et  al.  (36). 
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These  data  also  indicate  that  the  proliferation/maturation 
requirements of mature and immature NK cells are distinct. 
Unlike previous reports, we detected two distinct NKR- 
P1A  +  NK cell populations  in the  cultures.  Similar to NK 
cells derived in other culture conditions (6,  8,  10,  12), one 
subset  is  phenotypically  and  functionally  mature  and  ex- 
presses CD56 and, although only on a minor proportion of 
the  cells,  other  surface  antigens  of mature  NK  cells,  e.g., 
CD16,  CD2, and CD8.  It is possible that CD16 represents 
a late NK cell differentiation antigen,  as is the case for my- 
eloid cells  (37), that the culture conditions provided do not 
allow complete phenotypic maturation, and/or that cytokines 
inducing CD16 expression, e.g., platelet-derived growth fac- 
tor (38), are missing. 
The second subset,  NKR-P1A+/CD56 -, is functionally 
and phenotypically immature  and has a surface phenotype 
similar,  if  not  identical,  to  that  of  the  NKR-P1A+/ 
CD56  /CD16-  subset  we  have  identified  in  both  adult 
and  neonatal  PBL.  The  existence  of circulating immature 
NK  cells  had  been  postulated  by Nagler et  al.  (34),  who 
described a CD56+/CD16 -  PBL subset that, unlike mature 
NK  cells,  expresses  IL-2Ro~,  once  stimulated  with  IL-2 
proliferates in response to IL-4, and does not express IFN-~/ 
mRNA.  Being  CD56  and  not  cytotoxic,  the  CD16  / 
NKR-PIA + cells described here are distinct from that pop- 
ulation.  Given  the  limited  number  of circulating  NKR- 
P1A+/CD16-/CD56 -  cells,  no functional  data  are  avail- 
able yet for these cells isolated directly from PBL; however, A. 
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Figure  6.  Cytotoxac activity 
and TIA-1  expression in NKR- 
P1A  + cell subsets NKR-P1A+/ 
CD56 +  or  CD56  cells were 
separated from 30-d  cultures of 
Lln- cells, as described in Fig  4 
and  m  Material  and  Methods. 
(A) Spontaneous cytotoxic]ty of 
total  ('),  CD56 +  (O),  and 
CD56-  (0)  NKR-P1A  +  cells 
was  measured  in  a  4-h  SlCr- 
release assay with  the  indicated 
number of effector cells and 104 
K562  target  cells/well.  Experi- 
ment  representative of five per- 
formed. (B) Cytoplasmic expres- 
sion of TIA-1  was analyzed by 
unmunohastochenmtry, mAb C8 1 
(ann-IL-12,  p40) was  used  as 
negative control. Arrows m&cate 
cytoplasmic staining. Magmfica- 
tlon, 500. 
based on the in vitro data, it can be hypothesized that these 
cells represent  circulating immature  NK  cells that  can  be 
recruited to functional maturation. 
Several possibilities may explain the presence in our cul- 
tures  of both  mature  NK  cells and  those in  an  apparently 
arrested state of development. Lin  populations are hetero- 
geneous and may contain NK  cell progenitors at different 
stages of differentiation and with distinct growth factor re- 
quirements.  The most mature ones, as previously proposed 
(9,  12),  may respond readily to  IL-2, and/or be induced 
to differentiate by factors endogenously produced or added 
exogenously. More immature progenitors may need addi- 
tional factors that are not provided or produced in the cul- 
tures.  Alternatively, and/or  in  addition,  the  culture  con- 
ditions  likely  change  during  the  course  of  30  d;  e.g., 
myelo-monocytic cells, which may produce factors affect- 
ing NK  cell differentiation  (39)  are  present  only  at  early 
times, and any cell only partially differentiated by the time 
these changes occur may be unable to mature completely. 
The  distinctive marker of the immature  NK  cell subset 
reported here is NKR-P1A. This is a type II integral mem- 
brane  protein with  a  region  of sequence  homology with 
C-type lectlns in its extracellular domain (21) and 47% ho- 
mology with rodent NK1L-P1,  shown  to transduce activa- 
tory  signals  (40)  and  capable  of binding specific carbohy- 
drate moieties (41,  42).  The  role and  the  natural ligand(s) 
of this molecule,  and its biological significance on  human 
NK and T  cells is still to be defined, but its usefulness as a 
marker  of NK  cell  development  is  clear.  NKtL-P1A  ex- 
pression on NK cells differentiated from immature progen- 
itor cells has not been analyzed in previous reports,  and it 
remains to be established whether the subset identified here 
can be generated from purified CD34 +  cells, as those used 
in most other reports.  NK cell progenitors are enriched in 
the CD7+/CD34 + cell population (7). Unlike CD7, NKR- 
P1A  is  absent  on  umbilical cord  blood  CD34 +  cells, but 
becomes expressed on NK  cells within 7  d  in the primary 
cultures  described  (data  not  shown),  indicating  that  the 
NKR-PIA+/CD56-/CD7  +  cells represent  NK  cells at  a 
later stage of differentiation than the CD34+/CD56-/CD7  + 
ones. 
The  NK1L-PIA+/CD56 -  cells  are  not  cytotoxic.  The 
possibility that their functional incompetence is only appar- 
ent,  and  limited  to  the  target  cells  used,  cannot  be  ex- 
cluded. However, the observation that after secondary cul- 
ture these cells can kill the same targets suggests that this is 
not the case. The inability of these cells to kill is unlikely to 
depend,  primarily, on lack of cytotoxic granule-associated 
proteins because TIA-1 and perforin were present in a sig- 
nificant percentage  of the  cells, and SE-1  was functionally 
active both  in  total cell lysates and  at  the  single cell level 
(not shown). Also, surface adhesion molecules known to be 
involved in target cell recognition (the LFA-1/CD18 com- 
plex)  (43,  44)  are  expressed  on  the  NKRPIA+/CD56  - 
cells at  a  density similar to  that  on  the  CD56 +  cells  (data 
not shown).  These data support the hypothesis that lack of 
cytotoxiclty depends on the absence of one or more func- 
tional cytotoxicity-triggering elements in the CD56-  cells: 
these may include  target recognition receptor(s) yet to  be 
identified and/or biochemical pathways of signal transduc- 
tion.  Irrespective of the  reason,  our data indicate that  ex- 
pression  of cytotoxic granule-associated proteins precedes 
functional  maturation  of the  machinery  needed for  target 
cell recognition  andtriggering  of cytotoxicity. This  con- 
1852  Human NK Cell Dlfferennation Table  2.  Induction  of CD56 Expression  on NKR-PIA+ /CD56  -  Cells 
Total cell number/well, X  106; 
Culture conditions*  mean +  SD (n)*  Percent CD56 + cells; mean -+ SD (n)* 
IL-2  0.9  +  0.6 (3)  6.3  +  6.9 (3) 
IL-2  +  IL-12  0.8  -+ 0.6 (3)  9.5  +  5.6 (3) 
Daudi  +  IL-2  0.8  +  0.1  (3)  8.0 +  6.9 (3) 
Daudi  +  IL-2 +  IL-12  0.9 +_ 0.2 (7)  43.2  +  25.9 (7)5 
*NKR-P1A+/CD56  cells  (10  6 cells/well) were purified from 30-d primary cultures and cultured for 10 d in the con&tions hsted, as described in 
Materials and Methods  rlL-2, 50 U/ml; rlL-12, 1 ng/ml; 30-Gy irra&ated Daudl cells, 2  ×  10S/well. 
*Percent CD56 + cells was determined by lmmunofluorescence; n, number of experiments performed 
~P <0 05, Daudi +  IL-2 +  IL-12 vs each of the other condations; two-tailed, two-sample t test. 
clusion  is  also  supported  by  the  reported  existence  of  a 
noncytotoxic  immature NKI.1,  NKR-P1C  +  (45),  NK  cell 
subset  in  mice  with  ablated  bone  marrow  (15).  Like  the 
human  NKR-P1A  +  cells described here  (data not shown), 
these  cells  bind  targets,  lack  other  differentiation  markers 
characteristic  of mature  NK  cells,  and have been hypothe- 
sized  to  represent  NK  cells that are  frozen at an immature 
stage of differentiation and that, to undergo  complete mat- 
uration,  require  factors  provided  only in  the  environment 
of an intact bone  marrow.  Similarly, our culture conditions 
likely  lack  factors,  present  in  vivo,  needed  for  complete 
NK  cell differentiation. 
The  NKR-PIA+/CD56  -  subset  is  reduced  to  develop 
into functional NK  cells in conditions  different from those 
supporting the initial differentiation of Lin-  cells along the 
NK  cell lineage.  IL-2,  either alone or in combination  with 
feeder  cells,  is  insufficient  to  induce  further  phenotypic 
maturation of these cells and only the addition of IL-12 al- 
lows  this process,  indicating that IL-12  is necessary for the 
maturation of NK  cell progenitors in vitro.  Given the lim- 
ited  number  of cells  available  for  these  studies,  we  tested 
cytotoxicity  only  an  the  cultures  in  which  phenotypically 
mature  cells could be detected,  and we  cannot exclude the 
possibility  that  the  cells  derived  from  the  cultures  in  the 
presence  of IL-2,  alone  or with  the  B  lymphoblastoid cell 
line, although phenotypically immature,  are also  cytotoxic. 
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Figure  7.  Cytotomc acnvlty of NKR-P1A+/CD56 -  cells before and 
after  secondary cukure  CD56  cells were  purified from 30-d primary 
culture (0) and cultured for 10 d in secondary cultures  (A) as described m 
Materials  and Methods. Spontaneous cytotoxacity  was measured in a 4-h 
SlCr  release  assay using K562 target cells. Experiment representative of 
chree performed. 
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Figure  8.  IFN-'/  and  TNF-ee  mRNA  expression  m  NKR-PIA+/ 
CD56- cells before and after secondary culture. Cells were prepared and 
cultured as in Fig. 7. R_T-PCR analysis was performed on R.NA extracted 
from the cells after 30-d primary cultures and after secondary culture with 
IL-2,  IL-12,  and Dau& cells, as indicated. After separation,  cells were in- 
cubated without (-)  or with (+)  PMA (10-" M)  and Ca  2+ lonophore 
(A23187,  0.1  #xg/ml) for 2 h. The P,T-PCR products were Vlsuahzed af- 
ter ethldmm bromide staining,  after agarose  gel electrophoresls.  Mol wt 
markers were 4>X174 DNA/HaelII. NK, umblhcal cord blood NK cells; 
Mock, no mRNA/cDNA template in either RT or PCR. 
1853  Bennett et al. Table 3.  Cytokine  Production in Primary and Secondary Cultures 
Culture conditions*  Cell population  IFN-y, U/ml +  SD (n)*  TNF-c~, U/nil _+ SD (n)~ 
Primary culture, day 15 
Secondary culture, day 8 
Total cells  1.3 +  1.6 (3)  1.6 +  1.7 (3) 
CD56 +  486.0  -+ 198.0 (3)  161.0 (1) 
CD56-  532.0  +  101.0 (3)  319.0 (1) 
*In pnmary cultures, Lm- cells were cultured (2 ×  10  s cells/well) on S14hSCF  22° feeder cells with rlL-2 (50 U/ml). The CD3  /NKR-P1A  + cell 
subsets, purified from 30-d cultures, were mcubated, separately, with 30-Gy Irradiated Daudl cells to which rlL-2 (50 U/ml) and rlL-12 (1 ng/ml) 
were added on days 0, 4, and 7 
*IFN-y and TNF-oe were detected by ILIA in the cell-free supernatants  collected on the days indicated, n, number of experiments performed. 
Based on the data in the murine system (45), however, we 
consider  this  unlikely.  Whether  the  B  lymphoblastoid 
feeder cells are necessary (possibly providing cell-cell con- 
tact or cytokines), or IL-12 is sufficient in the  absence of 
IL-2 and/or feeder cells, and whether the effect is mediated 
by this cytokine directly, or indirectly via induced produc- 
tion of additional factors,  is  under investigation. In IL-12 
p40  knockout mice  (46)  the  absolute number and subset 
composition of NK cells have not been analyzed; however, 
only a modest, though significant, decrease in spontaneous 
cytotoxicity has been reported. On this basis we consider it 
likely that, even if proven sufficient to support late NK cell 
differentiation, IL-12 is not the sole cytokine able to medi- 
ate  this effect.  One likely candidate for this is  IL-15, that 
induces NK cell differentiation from CD34 + cells (11) and, 
in the culture conditions reported here, can induce genera- 
tion, from Lin- cells,  of NK cells that  are phenotypically 
more differentiated than those induced by IL-2 (Zamai, L., 
E.  Rosati,  I.M.  Bennett,  and B.  Perussla,  manuscript in 
preparation). IL-12 induces myeloid cell differentiation act- 
ing with SCF, IL-3, or GM-CSF (47, 48). Unlike IL-2 and 
IL-15 (11),  IL-12 does not support NK cell differentiation 
when used instead of IL-2 under identical primary culture 
conditions (48): thus, the effects of IL-12 on NK cell dif- 
ferentiation appear  to  be  stage-specific.  Whether  or  not 
IL-15 has similar effect on the NKR-P1A+/CD56  -  imma- 
ture NK cells is under investigation. 
Mature  NK  cells  produce  several  cytokines  including 
IFN-  3,  and  TNF-cl  (49,  and  reviewed  in  reference  50). 
The  NKlL-P1A+/CD56  -  cells,  like  the  CD56+/CD16 - 
cell subset described by Nagler et al.  (34),  express TNF-ci 
but not IFN-y mlLNA after primary culture. TNF-cl ex- 
pression is unlikely to  reflect myeloid cells contamination 
because MSE mlkNA was not detectable in the same con- 
ditions,  and  cells  with  myeloid  phenotype  were  absent. 
The presence of TNF-ot mRNA  in both the CD56 + and 
the  CD56-  NKtL-PIA  +  cell subsets suggests that  expres- 
sion of this cytokine occurs early during NK cell matura- 
tion, whereas IFN-y production represents a more special- 
ized function, acquired only at later differentiation stages. 
The possible biological significance of this  remains to  be 
determined. 
Based on these observations, it may be speculated that at 
the onset of an immune response to intracellular pathogens 
IL-12 plays  a  role  to  activate  maximally the  nonadaptive 
system of defense, in which NK cell are potent and essen- 
tial effectors, both enhancing the functional activity of ma- 
ture NK cells, and inducing maturation of circulating pre- 
cytotoxic NK cells. 
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